ABSTRACT
W
est syndrome (WS) is an epileptic encephalopathy characterized by epileptic spasms, a specific pattern on electroencephalography (EEG) of hypsarrhythmia, and developmental regression. While WS has a variety of causes, the etiology remains unclear in 20% of patients. 1 Recent advances in neuroimaging have revealed underlying pathologies such as focal cortical dysplasia in these patients. 2 We and others have reported hypometabolism on PET and hypoperfusion on SPECT during the early stages of cryptogenic WS. [3] [4] [5] [6] [7] [8] [9] Detecting these findings is useful for both predicting long-term outcomes and detecting underlying lesions. [3] [4] [5] [6] 8, 9 Further progress of modern neuroimaging techniques is expected to clarify the underlying pathology in patients with WS of unknown etiology. Diffusion tensor imaging is an MR imaging technique that can provide information about the orientation and integrity of white matter fibers. This method is useful for detecting underlying abnormalities in the white matter of patients with various neurologic disorders. Because it is hypothesized that widespread networks of cortical and subcortical structures are involved in the generation of epileptic spasms and hypsarrhythmia in WS, 10 DTI
should help reveal the pathophysiology of this syndrome.
In this prospective study, we performed serial DTI studies from the onset of epilepsy to assess underlying white matter abnormalities in patients with WS of unknown etiology. We compared the results of DTI with cognitive and motor development, EEG findings, and seizure outcomes. We also compared distributions of abnormal findings on DTI with those of hypometabolism on [ 18 F] fluorodeoxyglucose-PET.
MATERIALS AND METHODS
This study was approved by the research ethics committee at Nagoya University Graduate School of Medicine.
Patients
Between 2007 and 2014, we performed DTI in consecutive patients with new-onset WS of unknown etiology seen in Nagoya University Hospital. We diagnosed WS from epileptic spasms in clusters that were recorded by simultaneous video-EEG recording and typical interictal EEG findings of hypsarrhythmia. Inclusion criteria for patients were as follows: 1) normal birth and absence of any etiologic factors related to WS, 2) normal development before the onset of spasms and the absence of neurologic abnormalities at onset, 3) occurrence of spasm clusters without any other types of seizures before the onset of spasms, and 4) normal findings from laboratory tests, CT, and MR imaging. Chromosomal abnormalities were investigated with G-banding or array comparative genomic hybridization. Patients were initially treated according to the following protocol: Clonazepam was administered for 1 week. When other oral antiepileptic drugs were started in previous hospitals, they were continued for 1 week. If oral antiepileptic medications failed to control the spasms, adrenocorticotropic hormone (ACTH) therapy was started. In the present study, 1 patient did not receive ACTH therapy. In ACTH therapy, synthetic ACTH was injected intramuscularly at 0.015 mg/kg/day for 2-4 weeks, followed by alternate-day administration for 1 week. The effectiveness of each drug was evaluated on the basis of the frequency of spasms and interictal EEG findings.
Controls
We used 2 control groups to compare the images of patients with WS. The first control group consisted of 13 children with a mean age of 12.2 Ϯ 3.0 months (range, 8 -18 months) and was used for the analysis of patients at 12 month of age. The second control group comprised 15 children with a mean age of 24.8 Ϯ 4.5 months (range, 18 -27 months) and was used for the analysis of patients at 24 months. Controls had undergone MR imaging because CNS abnormalities had been suspected on presentation but were later ruled out. Conventional MR imaging did not show any abnormalities in controls. Final diagnoses in controls were nonpathologic sleep myoclonus, nonpathologic motion arrest, myasthenia gravis, pigmented macules without neurocutaneous disorders, peripheral facial nerve palsy, breath-holding spell, shuddering attack, nonpathologic macrocephaly, and short stature.
Image Acquisition for DTI
All patients underwent DTI 3 times. The first scans were obtained at the onset of spasms before ACTH therapy; the second, at 12 months of age; and the third, at 24 months of age. We used the second and third scans for the present study. The second and third scans were obtained Ͼ1 month after the end of ACTH therapy to avoid the effects of brain shrinkage caused by ACTH. In our previous study evaluating MR imaging by visual inspection, we did not detect cerebral shrinkage caused by ACTH therapy on MR imaging performed Ͼ1 month after the end of ACTH therapy. 5 Scans were obtained as part of the clinical routine to search for underlying pathology. Before each scan, we explained to parents that the results would be used for research, and informed consent was obtained. All patients were sedated with oral chloral hydrate before the examination. When patients did not appear sufficiently sedated after chloral hydrate intake, intravenous midazolam or ketamine was administered.
MR imaging examination was performed on a 3T scanner (Magnetom Trio A Tim System; Siemens, Erlangen, Germany) with a 32-channel phased array head coil. DTI ). In addition to DTI data, the following conventional MR images were acquired to examine structural abnormalities: axial T1-weighted, T2-weighted, fluid-attenuated inversion recovery images, sagittal T1-weighted images, and coronal T2-weighted images.
Evaluation of EEG, Seizure, and Neurodevelopmental Outcomes
We used EEG findings at 12 months of age for evaluating the early response to initial treatments. EEG findings at this age were classified as normal or abnormal on the basis of the remaining epileptiform discharges during wakefulness and sleep. Evaluation of seizure outcome was performed between August and December 2014. The age at the evaluation ranged from 2 to 8 years (median, 5 years). The information was obtained from the medical charts at Nagoya University or affiliated hospitals. Seizure outcome was categorized as follows: 1) free of seizures, when the patient had no seizures during the entire follow-up after the initial treatment with clonazepam or ACTH; or 2) persistent or recurrent seizures during the entire follow-up after initial treatment.
The developmental quotient (DQ) was estimated by using the Tsumori-Inage developmental questionnaire at 12 and 24 months of age. 11 This questionnaire was released in 1961 and is widely used in Japan. 9, 12 It consists of the 5 domains of gross motor skill, fine motor skill, sociality, activities of daily living, and language. Developmental status was considered as follows: 1) normal, when patients had a DQ of Ն70 at 24 months of age; or 2) delayed cognitive and motor development, when patients had a DQ of Ͻ70 at 24 months of age. While the DQ at 12 months tends to reflect development of motor function, the DQ at 24 months reflects language and cognitive function more than the one at 12 months.
FDG-PET
All patients underwent FDG-PET at onset and at 12 and 24 months of age. The scans were obtained to search for underlying pathologies and predict long-term outcome as in our previous studies. 5, 9 All patients were sedated by chloral hydrate suppository during the PET examination. PET images were analyzed with visual inspection by 3 pediatric neurologists (J.N., T.F., and H. Kidokoro). All 3 pediatric neurologists were regularly involved in neuroimaging studies and had experience in the interpretation of pediatric PET images. PET findings were evaluated as in our previous studies. 5, 9 Regional hypometabolism was defined as a regional decrease in FDG accumulation in Ն2 gyri on Ն2 sections.
Image Processing
DTI analyses were performed by using tract-based spatial statistics (TBSS) in the fMRI of the Brain software package (FSL; http:// www.fmrib.ox.ac.uk/fsl). 13 For each subject, all DTI was corrected for eddy current-induced distortion and subject motion effects. The correction was performed by affine registration to a reference volume that is included in the FMRIB Diffusion Toolbox (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FDT). A brain mask was created from the first B0 image. A diffusion tensor model at each voxel was fitted, and fractional anisotropy (FA), mean diffusivity, axial diffusivity, and radial diffusivity maps were computed. Next, the most representative FA image was first identified, and all FA data for a subject were aligned to this target image by nonlinear registration. The mean FA image was created and thinned to create a mean FA skeleton, which represents the centers of all tracts common to the group. Aligned FA data for each subject were then projected onto this skeleton, and the resulting data were fed into voxelwise cross-subject statistics. Statistical analysis was performed voxel by voxel to detect regions of significant differences in FA between the 2 groups of subjects, by using FSL Randomise (http://fsl.fmrib.ox.ac.uk/fsl/ fslwiki/Randomise) with 5000 permutations. The Threshold-Free Cluster Enhancement option in Randomise was used to avoid an arbitrary initial cluster-forming threshold. Age was used as a nuisance covariate of no interest. Results are reported at a corrected threshold of P Ͻ .05. TBSS analysis was performed between FA images of all patients and controls. Analyses were also performed between subgroups of patients with a DQ of Ͻ70 or a DQ of Ն70 at 12 and 24 months of age and controls.
Skeletons showing significantly reduced FA from those of controls at 12 months of age were extracted. These skeletons included whole clusters with significant reduction of FA in patients on TBSS analysis and did not include clusters of increased FA. Mean values for FA, mean diffusivity, and eigenvalues in the skeletons were calculated in each patient. Eigenvalues (1, 2, 3) correspond to the directional apparent diffusion coefficients as either principal axial diffusivity (1) or radial diffusivity ([2 ϩ 3]/2).
Statistical Analysis
Statistical analysis was performed by using SPSS, Version 19 software (IBM, Armonk, New York). We compared mean DTI parameters in the skeleton with significant differences on TBSS between patients and controls and determined correlations of parameters with the DQ at 12 months of age in patients. We also compared DTI parameters between patients with and without abnormal findings on EEG at 12 months of age and between patients with and without persisting or relapsing seizures after initial treatment.
On the basis of FDG-PET findings at 12 and 24 months of age, TBSS analysis of DTI at 12 and 24 months of age was performed between patients with regional hypometabolism and controls and between patients without regional hypometabolism and controls. This evaluation was performed because patients with regional hypometabolism may have focal underlying pathology that causes regional abnormal findings on DTI.
Comparisons of DTI parameters between patients and controls, between patients with and without EEG abnormalities, and between patients with and without persisting or relapsing seizures were performed by the nonparametric Mann-Whitney U test or the Kruskal-Wallis test and post hoc analysis with Bonferroni correction for analysis among 3 groups of patients with and without seizures and controls, and those with normal or abnormal EEG findings and controls. Correlations of parameters in patients with DQ were determined by the Spearman correlation coefficient (r). Significance was established at P Ͻ .05.
RESULTS
Twenty-three patients (14 boys) with WS of unknown etiology underwent DTI during the study period. ACTH therapy was performed as an initial treatment in 22 patients, while the remaining patient did not receive ACTH therapy. The interval from the onset of spasms to initial treatment was 0 -4 months (median, 1 month). After initial treatment, 15 patients were categorized as free of seizures; 6 patients experienced recurrence of spasms; and 2 patients showed partial seizures. EEG at 12 months of age showed normal findings in 11 patients, hypsarrhythmia in 3, and focal spikes in 9. In 21 of 23 patients, the presence or absence of abnormal findings on EEG was the same at 12 and 24 months of age. In 1 patient with hypsarrhythmia and 1 with focal spikes at 12 months of age, the EEG findings were normal at 24 months. In 15 patients free of seizures after initial treatment, the EEG findings at 12 months of age were normal in 10 patients and showed focal spikes in 5. The DQ ranged from 33 to 100 (median, 77) at 12 months and from 29 to 123 (median, 75) at 24 months of age.
TBSS Analysis between Patients and Controls
Two patients could not undergo DTI at 12 months of age, and DTI of another patient showed motion artifacts. TBSS analysis at 12 months was thus performed between 20 patients and 13 controls. TBSS revealed reduced FA in the corpus callosum, deep white matter, and subcortical white matter in the temporal lobes of patients (Fig 1A) . No areas of increased FA were identified.
DTI of 3 patients at 24 months of age showed motion artifacts, so DTI of the remaining 20 patients was used for analysis. TBSS at 24 months of age did not show any significant difference between all patients and controls (Fig 1B) . Comparisons between the 10 patients with a DQ of Ͻ70 at 24 months of age and controls revealed reduced FA values in widespread white matter in patients (Fig 1C) . No areas showed significantly different FA between patients with a DQ of Ն70 and controls.
Parameters in the FA Skeleton with Significant Differences on TBSS and Developmental or Seizure Outcomes
Mean values of FA, mean diffusivity, and eigenvalues in the FA skeleton showing significant FA reduction in patients on TBSS at 12 months of age are shown in the Table. Axial diffusivity along the axonal direction 1 and mean diffusivity showed no significant difference between patients and controls. Radial diffusivity perpendicular to the axonal direction ([2 ϩ 3] / 2) was significantly higher in patients (P ϭ .007).
The DQ at 12 months of age showed a significant positive correlation with FA (r ϭ 0.64, P ϭ .003) and negative correlations with radial and mean diffusivity (r ϭ Ϫ0.60, P ϭ .005 and r ϭ Ϫ0.53, P ϭ .017, respectively) (Fig 2) . No correlation was identified between axonal diffusivity 1 and DQ at 12 months of age.
Patients (Fig 3) . No significant differences in 1 were seen between patients with and without seizures or with and without EEG abnormality at 12 months of age.
Mean values of diffusion tensor imaging parameters in

Correlation of DTI and FDG-PET
FDG-PET at 12 months of age showed regional cortical hypometabolism in 16 patients. The regions of hypometabolism at 12 months were unilateral temporal in 3 patients, unilateral frontal in 2, unilateral parietal in 1, unilateral frontotemporal in 6, unilateral parietotemporal in 2, unilateral temporooccipital in 1, and unilateral frontoparieto-temporal in 1. FDG-PET at 24 months of age revealed regional cortical hypometabolism in 8 patients and normal findings in the other 12 patients on visual inspection. Of 16 patients with PET hypometabolism at 12 months, 6 had relapse or persistent seizures and 10 had abnormal findings on EEG at 12 months. Of 8 patients with PET hypometabolism at 24 months, 5 had seizure relapse or persistent seizures and 5 had abnormal findings on EEG at 24 months. At 12 months of age, hypometabolism was on the left side in 10 patients, the right side in 5, and in the bilateral temporal lobes in 1. At 24 months of age, hypometabolism was present in the left temporo-frontal lobe in 3 patients, left temporal lobe in 1, right temporo-frontal lobe in 2, right frontal lobe in 1, and right temporal lobe and right frontal lobe in 1. FA images of patients with right-sided hypometabolism were flipped, so that all regional hypometabolism would appear on the left side. We excluded 1 patient with hypometabolism in the bilateral temporal lobes to compare the laterality of the abnormality on PET and DTI and 2 patients with right or left frontal hypometabolism on TBSS analysis to focus on temporal lobe hypometabolism. At 12 months of age, TBSS between the 15 patients with left temporal hypometabolism and controls showed reduced FA in widespread white matter symmetrically. At 24 months of age, TBSS between the 7 patients with left temporal hypometabolism and controls showed reduced FA in widespread white matter and more prominent hypometabolism in the left temporal lobe compared with the right temporal lobe (Fig 4) . TBSS did not show FA reduction in 12 patients without PET hypometabolism at 24 months of age compared with controls.
DISCUSSION
DTI in patients with WS of unknown etiology showed widespread white matter abnormalities at 12 months of age. While axial diffusivity showed no significant differences compared with controls, radial diffusivity was significantly increased. The DQ correlated positively with FA and negatively with radial or mean diffusivity. Patients with persistent EEG abnormality and seizures had more prominent DTI abnormalities than patients with normal EEG and no seizures after initial treatment. Although DTI at 24 months of age did not show significant differences in the com- parisons of all patients and controls, patients with poor developmental outcomes still showed decreased FA. Patients with lateralized regional hypometabolism on PET showed more prominent DTI abnormalities ipsilateral to the side of hypometabolism. This is the first report revealing abnormal findings on DTI in patients with WS of unknown etiology. A recently published study by Fosi et al 14 did not show a significant difference between patients with WS and controls on TBSS analysis of DTI. The timing of MR imaging scans in their study was not clearly described and seems to be variable. The standardized timing of MR imaging in our study may be one of the reasons that MRI revealed significant abnormality.
Several factors can cause abnormal findings on DTI, such as axonal properties, fiber coherence, demyelination, and white matter maturation, especially in infants. [15] [16] [17] Cortical malformation often affects the underlying white matter and the cortex 18 and could disrupt white matter tracts and cause reductions in anisotropy. 19, 20 White matter abnormality could also be attributed to propagation of epileptic activities along white matter tracts. 21 ACTH therapy also possibly affects white matter properties, though we performed DTI Ͼ1 month after the end of ACTH therapy to avoid the effects of ACTH. Another major factor contributing to DTI changes in infancy is white matter maturation. In this period, age-related changes in water diffusion-based properties are observed in white matter tracts. 17, [22] [23] [24] [25] [26] We have reported delayed myelination on T2-weighted imaging at approximately 10 months of age in patients with cryptogenic WS. 5 In an unpublished study of ours, a significant decrease of FA was revealed in patients with delayed myelination on T2WI at 12 months of age. The diffuse abnormal findings on DTI in the present study were prominent at 12 months of age and had resolved by 24 months of age in patients with good developmental outcomes. Dynamic changes in abnormal findings on DTI resemble the pattern of delayed myelination in our previous study of WS, suggesting that delayed white matter maturation may contribute to the abnormal findings on DTI. Furthermore, FA reduction in our study was attributed to increased radial diffusion perpendicular to the axonal direction. Increased radial diffusion suggests abnormal myelination in experimental models, though pathologic correlates of abnormal findings on DTI in humans are still unclear. 15, 16 Given the dynamic changes in abnormal findings on DTI and the increased radial direction, delayed myelination may be the most likely pathology underlying widespread symmetric abnormal findings on DTI at 12 months of age.
A strong correlation was observed between DTI parameters and cognitive and motor development in our study. Correlations between DTI and cognitive function have been reported in healthy children and those with various pediatric disorders. Widjaja et al 27 studied correlations between abnormal findings on DTI and neuropsychological function in children with nonlesional focal epilepsy, revealing that widespread white matter abnormalities were associated with impaired neuropsychological function. The impairment in white matter may reflect disruption in the connectivity of cortical processing networks, which is necessary for the development of cognition. 27 In our study, delayed maturation of widespread white matter areas contributed to delayed cognitive and motor development. This abnormal white matter included many fiber tracts that are important for language and cognitive function, such as the uncinate fasciculus and inferior longitudinal fasciculus. Evaluation of DTI can thus facilitate objective assessment of the developmental status in a patient with WS. We revealed a difference in DTI parameters between patients with and without abnormal findings on EEG and those with and without seizures after treatment. Juhász et al 10 hypothesized that widespread corticosubcortical circuits are involved in epileptogenic activity of patients with WS. Epileptiform activity from the primary cortical abnormality stimulates brain stem structures, and interactions of the brain stem with the striatum and cortices induce hypsarrhythmia on EEG. 10 Persistent or recurrent epileptic activity may have disturbed white matter maturation and led to abnormal findings on DTI in our study. EEG findings during the follow-up period reportedly showed strong correlations with cognitive and motor development. 28 Our findings suggest that chronic epileptic activity may cause developmental regression by disturbing white matter maturation, though there is the other possibility that preexisting white matter abnormalities might lead to the poor outcome of seizures and EEG findings. The persistent abnormal findings on DTI at 24 months in children with poor developmental outcome may be multifactorial. Delayed maturation of white matter, microstructural damage by epileptic activities, or the underlying cause of epilepsy may contribute to the reduction in FA values. At 24 months of age, distributions of abnormal findings on DTI corresponded to those of PET hypometabolism, though the abnormal findings on DTI were still widespread and bilateral. Regional PET hypometabolism in patients with WS reportedly suggests focal cortical dysplasia. 2 Focal cortical dysplasia often involves white matter changes, and a pathologic study has revealed a reduced number of myelinated axons in the white matter. 18 DTI is reported to show abnormality in the subcortical and deep white matter subjacent to areas of focal cortical dysplasia. 20 From these observations, the asymmetric abnormal findings on DTI corresponding to areas of PET hypometabolism may represent white matter changes related to the underlying pathology, such as focal cortical dysplasia. In contrast to the reversible FA reduction due to delayed myelination at 12 months of age, abnormal findings on DTI at 24 months of age in patients with poor seizure and developmental outcomes appear to represent persistent microstructural abnormalities. This hypothesis should be proved pathologically or by other imaging techniques such as 7T MR imaging. Our study has some limitations. First, control subjects were recruited from among patients who had undergone screening scans for CNS abnormalities. Although CNS abnormalities were ruled out clinically, the possibility of underlying CNS lesions cannot be excluded. Second, the ages of patients and controls were not the same. We recruited control subjects with the same mean age as that of patients and used age as a nuisance covariate of no interest on TBSS analysis to reduce the effects of differences in age. However, the effects of the difference in age may not be eliminated completely. Another methodologic limitation is that DTI was performed with 12 directions that were relatively small in number. DTI with more directions and information from the Human Connectome Project (http://humanconnectome.org/) may enable more detailed analysis of white matter fibers. Several clinical factors affect developmental outcome, such as the adverse effects of antiepileptic drugs and the delay of initial treatment. Although we did not use phenobarbital, phenytoin, or topiramate, which were reported to have possible adverse effects on cognitive function, there was the possibility that antiepileptic drugs affect the cognitive function. It has been reported that a delay of initial treatment was a risk factor for poor developmental outcome. 29 In our study, only 4 patients had an interval of 2 months or longer from the onset of spasms to initial treatment, and most of the patients had a short treatment lag. Therefore, it is not likely that the delay of treatment caused the abnormal findings on DTI and poor developmental outcome.
CONCLUSIONS
DTI revealed white matter abnormalities in patients with WS of unknown etiology. These DTI abnormalities correlated with cognitive and motor development, seizure outcome, EEG abnormality, and PET hypometabolism. Serial DTI appears useful for assessing maturational status and detecting underlying pathology. The hypothesis of delayed myelination and microstructural abnormality causing the abnormal findings on DTI needs to be assessed by pathologic correlation, higher resolution neuroimaging, and correlation with therapeutic interventions.
